Background Malaria is a major cause of morbidity and mortality in early childhood, yet its consequences for health and education during the school-age years remain poorly understood. We examined the eff ect of intermittent preventive treatment (IPT) in reducing anaemia and improving classroom attention and educational achievement in semi-immune schoolchildren in an area of high perennial transmission.
Introduction
Children living in areas of high malaria transmission rapidly acquire immunity to malaria in early childhood; by the time they reach school age, the risk of clinical attacks and death has reduced. [1] [2] [3] However, many school-aged children continue to harbour asymptomatic parasitaemia, which can cause anaemia. 4 Although malaria might have an adverse eff ect on cognition and education outcomes, evidence for this has so far been lacking, 5, 6 and the case for school-based malaria control has not been established. [7] [8] [9] Historically, malaria chemoprophylaxis given to African schoolchildren was associated with lower rates of malaria parasitaemia and severe anaemia, fewer clinical attacks and malaria deaths, 10, 11 and reduced school absenteeism because of malaria. 12 One randomised trial has investigated the eff ect of clinical malaria on educational outcomes and provides evidence that school performance is related to the cumulative eff ect of previous malaria attacks 13 and that weekly chemo prophylaxis with chloroquine can improve school examination scores in Sri Lankan children.
14 However, this approach faces operational challenges, 15 and could prove less eff ective in sub-Saharan Africa, where subclinical infections predominate. An alternative strategy is intermittent preventive treatment (IPT), which involves the periodic mass administration of a full therapeutic course of an antimalarial drug, irrespective of infection status. We undertook a randomised controlled trial in western Kenya to investigate the effi cacy of school-based IPT in reducing anaemia and improving classroom attention and educational achievement.
Methods

Participants
This stratifi ed, cluster-randomised, double-blind, placebo-controlled trial was done between March, 2005, and March, 2006, in primary schools in Bondo district, western Kenya. Malaria trans mission is intense and perennial in this region, with two seasonal peaks (March-May and November-December). 16 By school age, clinical incidence declines to 0·25 episodes per child per year, although up to 50% of schoolchildren have asymptomatic malaria parasitaemia. 2, 3 Rural primary schools with 150 children or more, and over 15 children per class were eligible for inclusion. Schools located within 5 km from Lake Victoria were excluded to minimise confounding by Schistosoma mansoni. 17 Meetings were held in participating schools to explain the nature and purpose of the trial to parents or legal guardians, and written informed consent was obtained. Schoolchildren with parental consent and no history of adverse reaction to sulfa-based drugs were eligible for recruitment. Children with a haemoglobin concentration of less than 70 g/L at baseline, or known or suspected to be homozygous for sickle-cell trait or pregnant were not enrolled. The protocol was approved by the ethics review boards of Kenyatta National Hospital, Kenya; London School of Hygiene and Tropical Medicine, UK; and Danish National Committee on Medical Research Ethics, Denmark. Permissions were obtained from the Kenyan Ministry of Education, the District Education and Health Authorities, and head teachers. An independent data safety monitoring board monitored the trial and approved the analysis plan.
Procedures
We stratifi ed schools into three groups according to school examination performance in previous years, to account for diff erences in school quality and socioeconomic environment. Ten schools were randomly selected from each school-performance stratum, and within each stratum schools were randomly allocated to one of six coded drug groups by use of block randomisation (three pairs of either active drugs or dual placebo) according to a computer-generated random number list by an investigator (SEC) blind to drug group.
Children in intervention schools received IPT with one dose of sulfadoxine-pyrimethamine and three daily doses of amodiaquine on three occasions within a 12-month period (once each school term). IPT was fi rst given in May, 2005, coinciding with a seasonal peak in transmission, and then repeated in September, 2005, and January, 2006. Children absent from school were not treated. Children in control schools received dual placebo tablets over 3 consecutive days on each occasion.
Study drugs and placebos were manufactured by Cosmos Limited (Nairobi, Kenya) and labelled according to six coded drug groups. The code was held by the manufacturers and the data safety monitoring board, and revealed to the investigators only after completion of the statistical analysis. Dosage was by age. Participants were observed for 30 min after drug intake and treatment re-administered once more if spitting or vomiting occurred. Active drugs and placebos were similar in size and shape, but diff ered in taste. To preserve blinding, staff responsible for measuring health or education outcomes were unaware of drug group allocation, and analysis was done by a statistician with no previous involvement in the trial. Adverse events were monitored by the study team for 3 days after each treatment, and a further 28 days thereafter using a passive surveillance system in schools and local health centres. Travel costs were reimbursed and treatment charges waived. Adverse eff ects were monitored until the event was cured or had stabilised.
Incidence of clinical attacks was not measured, although a blood slide was prepared in children presenting with fever during school visits, and slidepositive cases were treated for malaria in accordance with national guidelines. Children with a haemoglobin concentration less than 70 g/L were given a course of haematinics. S mansoni-positive children received one dose of praziquantel (40 mg/kg). Children in all schools (intervention and placebo) received mass treatment twice a year for soil-transmitted helminth infections with one dose of albendazole (400 mg).
We investigated whether intermittent clearance of malaria parasitaemia would increase haemoglobin concentrations and, as a consequence, reduce anaemia and contribute to improved attention in class and educational performance. The primary endpoint was the prevalence of anaemia, defi ned as a haemoglobin concentration of less than 110 g/L, after 12 months of intervention. Secondary endpoints included prevalence and intensity of Plasmodium falciparum infection, mean haemoglobin concentration, sustained attention, and educational achievement.
Cross-sectional surveys were done in all schools in March, 2006, approximately 6 weeks after the last treatment. Finger-prick blood samples were obtained from all children with consent (aged 5-18 years) to assess haemoglobin concentration with a portable photometer (Hemocue, Angelholm, Sweden). Blood slides prepared for malaria were declared negative only after examination of 100 high-powered fi elds. Data on covariates, including bednet use and household socioeconomic status were obtained through a questionnaire administered to children in classes 2-7 (aged 7-17 years) during the fi nal survey. Height and weight were measured, and anthropometric indices calculated. For logistical reasons, only children in classes 5 and 6 were asked to provide stool samples, which were examined microscopically for helminth eggs by use of the Kato-Katz technique.
The eff ect of the intervention on cognitive abilities was investigated primarily by comparing diff erences in test scores of sustained attention given to a cohort of children in classes 5 and 6 (aged 11-16 years). This group was selected for testing because they were old enough to understand the test instructions. Secondary education outcomes included behaviour in class and educational achievement.
Two tests of sustained attention were undertaken on the day preceding health assessments. Both tests were adapted from the TEA-Ch (tests of everyday attention for children) battery 18 for group administration in groups of 15 or fewer, and given by a psychologist already trained in doing these tests. The tests involved listening to a tape and identifying diff erent sounds (counting sounds) and numbers (code transmission). In the counting sounds tasks children were required to count a series of electronic beeps played on the tape recorder, with varying delays of 0·3-10 seconds between sounds. Sustained attention was required to keep track of the number of sounds counted during delays and to be prepared for bursts of several consecutive sounds. In the code transmission tasks, a list of digits was read out aloud at the speed of one per second. Children were required to listen out for a "code"-two consecutive occurrences of the number 5-and then record the two numbers that preceded the code. A second test, included in the fi nal survey, required children to recall the three numbers that preceded the code. Before each test children were given a warm-up activity to familiarise them with the tape recorder, and three practice exercises. Internal reliability was high for both tests (Cronbach α>0·7 for counting sounds and α>0·8 for code transmission).
Classroom behaviour was assessed by teacher ratings of inattentive and hyperactive-impulsive behaviours in eight children randomly selected (by MCHJ) from each Nutritional status at baseline † ‡
Helminth infection at follow-up § 
Data are mean (SD) or n/N (%) unless specifi ed otherwise. *Data obtained at follow-up for all classes (5-18 years), apart from where indicated. †Measured at baseline among children who were enrolled in classes 5 and 6; also includes data for children in all classes in a randomly selected subset of 12 schools. ‡Anthropometric indices calculated on the basis of the 2000 Centers for Disease Control and Prevention growth charts. Weight-for-height standards were only available for children up to 121 cm in height and thus not calculated. Measured at baseline (ITT: 1141 placebo, 1321 IPT; PP: 744 placebo, 633 IPT). §Helminth infection was only measured among children enrolled in classes 5 and 6 at baseline. class by use of a computer-generated random number list. Behaviours were selected from the early childhood attention defi cit disorder scale. 19 Behaviours that were weakly correlated (<0·3) with the sum of other behaviour scores in piloting were deemed not to be strongly related to the overall trait and were dropped from the fi nal instrument. Internal reliability was high (Cronbach α>0·8). Assessment of educational achievement focused on learning which occurred towards the end of the intervention year, when the cumulative eff ect of repeated malaria treatment should have achieved maximum improvements in classroom attention. Knowledge of a content-based subject, taught during the last school term of the study, was measured in the two intervention groups. In January, 2006, teachers attended a 1-day training seminar to standardise the curriculum and teaching methods for social studies in classes 6 and 7. Children were tested at the end of the school term. A multiple choice exam was developed for each class. Internal reliability was adequate for both class exams (Cronbach α=0·62 for class 6 and α=0·59 for class 7).
Statistical analysis
On the basis of an observed anaemia prevalence of 38% at baseline and coeffi cient of variation between clusters of 0·27, a sample size of 12 schools with a total of 889 children in each arm was estimated to provide 80% power to detect a 30% reduction in the prevalence of anaemia in the intervention group compared with placebo at 5% level of signifi cance. 20 For the cognitive and education tests, where an intraclass correlation of 0·20 was assumed, a minimum of 15 schools per arm with 60 children assessed per school were needed to provide 80% power to detect an eff ect size of 0·25 in the intervention group compared with placebo at 5% level of signifi cance.
Data were analysed by intention to treat, excluding those children with missing data. A per-protocol analysis was also done, including only children treated on all three rounds and who completed the full 3-day regimen on each occasion, totalling 9 days of treatment. Children who received either haematinics for severe anaemia or active antimalarials for clinical malaria, or both, at any point during the study were excluded from the per-protocol analysis.
The eff ect of the intervention was analysed with methods appropriate for a cluster-randomised trial. 21 The prevalence, or mean, in each school was calculated and the unadjusted risk ratio, or mean diff erence (intervention-control), estimated in each stratum. An overall estimate of the eff ect of IPT was obtained by taking a weighted average of the stratum-specifi c estimates, the weights proportional to the number of schools per stratum, and 95% CIs were adjusted for observed between-school variance (Hayes R, London School of Hygiene and Tropical Medicine, personal Standard individual-level regression analysis, which incorporated stratum as a fi xed eff ect and all covariates, suspected a priori to be confounders or eff ect modifi ers, except the intervention eff ect, was used to calculate cluster-level expected values. Observed and expected values were compared by computing a residual, based on the ratio of observed to expected or the diff erence between observed and expected, for each school. Adjustment for covariates was undertaken replacing school-level means and proportions with covariateadjusted residuals. Additionally, the eff ect of intervention was assessed with adjustment for baseline characteristics among those children for whom baseline data were available. All analyses were undertaken using STATA version 9.2. This study is registered with ClinicalTrials.gov, number NCT00142246.
Role of the funding source
The sponsor of the study had no role in study design, data collection, analysis, interpretation, or writing of the report. SEC, MCHJ, BC, and SB had full access to the data and made the fi nal decision to submit for publication.
Results
The trial profi le is shown in fi gure 1. 4916 (73%) of 6758 school children enrolled in the trial were examined in the post-intervention survey 12 months later. The numbers of children lost to follow-up were similar in IPT intervention and placebo schools (26% and 28%, respectively). Health outcomes for children in the intervention group (n=2611) and placebo group (n=2305) were analysed according to intention to treat. Most children examined post-intervention had received treatment on all three occasions (more than 7 days of treatment were completed by 1946 [75%] and 1990 [86%] in each group), although only 1070 (41%) of children in the intervention group and 1394 (60%) in the placebo group had received treatment on all 9 days and were included in the per-protocol analysis of health outcomes. Children lost to follow-up and those who received incomplete treatment had similar baseline characteristics to children included in the per-protocol analysis (table 1 and table 2 ). Children in the IPT intervention and placebo groups were similar, although those in the IPT intervention group had slightly better nutritional status at baseline and fewer children were anaemic. Imbalances in helminth infection at baseline were successfully corrected with anthelmintic mass treatment and no marked diff erences in prevalence of helminth infections existed between intervention and placebo groups at follow-up. 818 children (76% of the original education cohort in classes 5 and 6 at baseline) participated in the tests of sustained attention post-intervention (436 in the IPT group, 382 in the placebo group). Children lost to follow-up were similar to those examined post-intervention (data not shown). Study endpoints and nutritional status in the IPT and placebo groups were similar at baseline, with slight diff erences in socioeconomic background (table 2 and  table 3) .
At follow-up, the prevalence of anaemia among schoolchildren in the IPT intervention group was signifi cantly lower than in the placebo group (table 4) . Results of the intention-to-treat analysis show that the protective effi cacy of the intervention against anaemia was 48% (95% CI 8-71; p=0·028; table 4). The adjusted risk diff erence was -0·06 (-0·01 to -0·11), equating to one case of anaemia prevented for every 16 children treated with IPT (95% CI 9-91 children). There were also fewer cases of severe anaemia (haemoglobin <70 g/L) in the IPT intervention group than in the placebo group (four and 16 cases, respectively). Similarly, post-intervention mean haemoglobin concentration was signifi cantly higher among children in the intervention group than among controls (table 4); adjusted diff erence 5·01 g/L (95% CI 1·62-8·41; p=0·005). IPT seemed to benefi t children across the whole distribution of haemoglobin concentrations, as shown by the diff erent distributions between the two groups (fi gure 2). Prevalence of P falciparum parasitaemia was lower Placebo and IPT intervention arms both contained 15 schools. *Risk ratios are presented for binary outcomes (anaemia and P falciparum occurrence), mean diff erences are presented for haemoglobin concentrations. Ratio of geometric means are presented for P falciparum intensity among those infected. †Intention-to-treat analysis: placebo n=2305, range 64-382 children per school; IPT n=2611, range 70-341 children per school. ‡Crude estimates account for the cluster-randomised trial design. Prevalence was calculated for each school, and the percentage shown represents the mean of these cluster-specifi c prevalence values. §Adjusted for stratifi ed, cluster-randomised, trial design. ¶Fully adjusted for trial design, age, sex, age/sex interaction, and nutritional status. All covariates measured at follow-up. ||Fully adjusted for trial design, age, sex, age/sex interaction, bednet use, and migration history. All covariates measured at follow-up. **Geometric mean parasite density calculated in parasite-positive children only. † †Per-protocol analysis: placebo n=1394, range 33-171 children per school. IPT n=1070, range 24-165 children per school. Table 4 : Eff ect of IPT on health outcomes: anaemia, haemoglobin, and P falciparum parasitaemia (95% CI 2-4 children). Among the subset of children infected with P falciparum at follow-up, mean parasite density was similar in the two groups (p=0·108).
Results of the per-protocol analysis, which included only children who received complete treatment during each treatment round, were similar to those of the intention-to-treat analysis (table 4). Analysis was also repeated on the subgroup of 2471 children for whom haemoglobin data at baseline were available, and yielded similar results (data not shown), confi rming that the observed diff erences are not attributable to slight baseline imbalances in nutritional status. Although no formal test of interaction was made, we also undertook prespecifi ed exploratory analyses to investigate the eff ect of intervention stratifi ed by age, sex, and anaemia status at baseline. The eff ect of IPT on anaemia did not diff er by age-group (data not shown), but the eff ect in girls was slightly greater than in boys (data not shown). An increase in mean haemo globin was seen in all sub groups of children, including those who were not anaemic at baseline (adjusted diff erence 7·42 g/L, 95% CI 3·05-11·79; p=0·0018).
At follow-up, scores for sustained attention were higher in the IPT intervention group than among controls for the counting sounds test (adjusted mean diff erence 1·80 [0·19-3·41; p=0·03; table 5) and the code transmission test (adjusted mean diff erence 6·05 [2·83-9·27]; p=0·0007). The eff ect size was 1·22 (95% CI 0·003-0·35) in the counting sounds test and 0·86 (0·09-0·88) in the code transmission test. There was no diff erence in mean score for inattentive or hyperactive-compulsive behaviours (table 5) or mean  educational achievement test scores (table 6) between study groups.
Seven children died during the 12-month intervention period: two in the IPT intervention group and fi ve in the placebo group. Cause of death was investigated, but could not be reliably ascertained in all cases. 23 serious adverse events were reported within 28 days after any mass treatment (includes children admitted for observation): 19 in the intervention group (of which three were judged to be possibly associated with treatment) and four in the control group. The most common serious adverse events were problems of balance, dizziness, feeling faint, nausea, or vomiting, which all occurred within 5 h of treatment. There was only one report of a severe skin reaction, which occurred in the placebo group. A further 13 adverse events were graded as moderate: six in the intervention group and seven in the placebo group. Mild events, such as nausea, headache, and prurititis, were more frequent among children receiving active drugs than among controls (49 and 33 reports, respectively).
Discussion
This trial has shown that school-based delivery of IPT once per term markedly reduced the prevalence of anaemia and asymptomatic parasitaemia in semiimmune school children in Kenya. We also show a benefi cial eff ect of malaria treatment on sustained attention of schoolchildren. Although only 73% of enrolled children were followed up, there were no marked diff erences in background characteristics or follow-up rates between study groups, suggesting that treatment eff ects were not caused by sample bias. Children receiving IPT were less likely to complete the full 3-day regimen, possibly because of the bitter taste of amodiaquine, but there was little evidence that this introduced bias since the characteristics of children who received complete and incomplete treatment were similar. Additionally, twice yearly anthelmintic treatment was given to all children (intervention and control), reducing helminth infection and anaemia in both groups from initial baseline levels. The resultant similarities in levels of helminth infection be tween study groups at follow-up, as well as nutritional status, provide convincing evidence that the effect on anaemia was mainly caused by reductions in malaria parasitaemia.
Our fi ndings are consistent with earlier observations that insecticide-treated bednet use is associated with reduced anaemia in adolescent schoolgirls, 22 suggesting that malaria control could have an important role in preventing anaemia in school-aged children. The size of the protective eff ect of IPT against anaemia is markedly greater than the protective eff ects seen in previous trials of anthelmintic treatment. [23] [24] [25] The eff ect is also comparable with, or larger than, reductions in the rates of anaemia seen following iron supplementation. [26] [27] [28] [29] Notably, previous trials often report that either young children or anaemic children benefi t most from intervention. However, in our study the protective eff ect of the intervention against anaemia did not diff er among age-groups, and signifi cant improvements in mean haemoglobin concentrations were seen in children who were not classifi ed as anaemic at baseline. This eff ect could have been achieved through the clearance of asymptomatic infections that would otherwise go untreated, thereby providing a window for haematological recovery. Decreased rates of destruction and removal of parasitised red blood cells, and improvements in the rate of erythrocyte production in the bone marrow 30 during parasite-free periods might contribute to improvements in haemoglobin concentration and anaemia. Long-acting drugs, such as sulfadoxinepyrimethamine, could also provide a period of prophylaxis immediately after treatment. 31 Concerns that chemoprevention might impede the development of antimalarial immunity and lead to rebound morbidity 15 might be less relevant in the age-group studied here, especially under intense transmission where early exposure promotes rapid acquisition of immunity before reaching school age. Treatment at 4-month intervals permits reinfection, maintaining levels of exposure-dependent immunity. Studies undertaken after completion of the trial showed the IPT strategy to be well accepted by teachers, parents, and schoolchildren (data not shown). Few serious adverse events attributable to study medication were recorded, and most symptoms were mild and self-limiting. Nonetheless, their occurrence in healthy asymptomatic children is not desirable. Placebo and IPT intervention arms both contained 15 schools. *Test included 20 counting sounds tasks, with up to 30 sounds per task. The total score was the number of times the sounds were counted correctly. †Crude estimates account for the cluster-randomised trial design. ‡Adjusted for stratifi ed, cluster-randomised, trial design. §Fully adjusted for strata, age, sex, class, baseline haemoglobin concentration, and sustained attention score at baseline. Baseline haemoglobin concentration and baseline sustained attention scores were not available for all children. ¶Test included two tests, in which children were required to record the two or three numbers, respectively, that preceded the code. Each test comprised 20 sets of code transmission targets. The total score was the number of times the target digits were correctly identifi ed. ||Data available for children in 14 schools in each treatment arm in per-protocol analysis; and for 14 schools in placebo arm in intention-to-treat analysis. **Fully adjusted for strata, age, sex, class, baseline haemoglobin concentrations. Baseline haemoglobin was not available for all children. Since attention function was only assessed post-treatment, no adjustments could be made for attention at baseline. Malaria early in life has been shown to impair later cognitive performance 32, 33 and clinical malaria aff ects school performance. 13, 14 Our results show that asymptomatic infection can also aff ect cognitive performance and that treatment against asymptomatic malaria improves sustained attention. However, by contrast with the Sri Lankan study, 14 we did not fi nd an improvement in educational achievement. Mean scores were generally low, suggesting that examined knowledge improved insuffi ciently in both placebo and intervention groups for a diff erence between them to be detected. Other possible reasons include low statistical power (<20%) because of greater than expected school-level clustering of educational achievement scores, short duration of follow-up, and the limited number of schoolchildren tested. Clinical attacks are less common in our population, which might also explain the diff erence between this and the Sri Lankan study. 14 The mechanism for the eff ect on cognition is not known, but it is possible that raised haemoglobin concentra tions had a role in improving attention. There is strong evi dence that iron-defi ciency anaemia leads to impaired cogni tive function, 34 although the cognitive eff ect of anaemia due to causes other than iron defi ciency is less well under stood. 32 Among many school health and nutrition interven tions previously assessed, only iron supplementation 35 and malaria prevention (in Sri Lanka 14 and the current study) have shown substantial improvements in cognitive function of around 0·5 SD or greater. 36 This large fi eld trial, using a randomised design, enabled the eff ect of malaria on sustained attention to be demonstrated, and provides strong evidence of a link between asymptomatic malaria and cognition. We did not, however, do an extensive battery of cognitive tests, and cannot determine whether asymptomatic malaria aff ects other aspects of cognitive function. Neither did we examine the eff ect of clinical attacks or absenteeism on anaemia or cognitive function. In other settings where the incidence of clinical attacks in schoolchildren is higher, this could adversely aff ect school performance and absenteeism. Knowledge of the eff ect of malaria on school performance and education is far from complete, but our fi ndings provide suffi cient evidence to indicate that this warrants more attention. School health programmes provide an eff ective vehicle to control anaemia and improve educational outcomes of school-aged children living in developing countries. 37 The pronounced eff ects of the IPT intervention on anaemia and malaria parasitaemia, and the eff ect on sustained attention, highlight the issue of the continued, and often unrecognised, malaria burden Placebo and IPT intervention arms both contained 15 schools. *Total number of correctly answered questions in a multiple-choice exam, specifi c to curriculum taught in each year group. †Crude estimates account for the cluster-randomised trial design. ‡Adjusted for stratifi ed, cluster-randomised, trial design. §Fully adjusted for strata, age, sex, teacher absenteeism, quality of schooling, and baseline haemoglobin concentration. Baseline haemoglobin concentration was not available for all children. Social science exams were not carried out at baseline. ¶Data available for children in 14 schools in the placebo arm. Table 6 : Eff ect of IPT on educational achievement among school-aged children in Africa and the potential of school-based programmes for tackling the problem. 9 Our fi ndings also illustrate the possible gains of integrating malaria control into broader school health programmes. 38 These results now need to be replicated in diff erent epidemiological settings. Further research is also needed to investigate the operational feasibility of the approach, and any long-term educational benefi ts.
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